AstraZeneca asks judge to nullify $215M drug-price lawsuit

Drugmaker AstraZeneca has asked an Alabama judge to nullify a jury verdict that ordered it to pay the state $215 million in damages in a Medicaid drug-price fraud suit. The state's 2005 suit accused the pharma with overcharging Medicaid by inflating drug prices. The jury awarded the judgment in February, but AstraZeneca appealed, saying that the state's attorneys hadn't proved their case, and had also violated a state law capping punitive damages. If the current judge doesn't throw out the verdict, the firm will appeal the judgment to the state's Supreme Court. 

To learn more about the case:
- read this Modern Healthcare article (reg. req.)

Related Article:
Drugmakers cut deals in price-inflation lawsuit

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.